Drug Development
Managing Your Career
-
Breaking News | Drug Development | Industry News
Kühne Holding AG Agrees to Acquire Aenova Group
Enlarges its investment portfolio to include healthcare and pharmaceutical assets.04.24.24
-
Breaking News | Collaborations & Alliances | Drug Development
BigHat Biosciences Partners with Janssen Biotech to Guide Antibody Discovery & Design
Collaboration will combine the drug discovery, clinical development and data science expertise from Johnson & Johnson with BigHat’s AI/ML platform.04.24.24
-
Breaking News | Collaborations & Alliances | Drug Development
Tetra Pharm Technologies & Glysious Partner to Develop Transdermal Combination Drugs
Aim to revolutionize transdermal release of ‘difficult-to-formulate’ compounds targeting the endocannabinoid system.04.24.24
-
Breaking News | Drug Development | Trials & Filings
Sanofi’s Rilzabrutinib Meets Primary Endpoint in ITP
Demonstrates significantly higher proportion of patients receiving rilzabrutinib achieved primary endpoint of durable platelet response versus placebo.04.23.24
-
Breaking News | Collaborations & Alliances | Drug Development
Tharimmune Announces Option for Novel HER2/HER3 Cancer Therapies
Obtains rights from Washington University to develop and incorporate human HER2 directed antibodies.04.23.24
-
Breaking News | Clinical Trials | Drug Development | Promotions & Moves
Calluna Names Senior Vice President of Clinical Operations & Pharmacovigilance
Margrethe Sørgaard offers 25 years’ experience in leading positions in clinical development and operation, medical affairs and drug safety/pharmacovigilance.04.23.24
-
Breaking News | Drug Development | Industry News
Lexeo Enters License Agreement for Friedreich Ataxia Treatment
Aims to expedite development of investigational gene therapy candidate LX2006 for the treatment of FA cardiomyopathy.04.22.24
-
Breaking News | Collaborations & Alliances | Drug Delivery | Drug Development
BioArctic, Eisai Ink Research Agreement for BAN2802 in AD
To evaluate potential new treatment combining BioArctic's BrainTransporter technology with an undisclosed Alzheimer drug candidate.04.22.24
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Ipsen and Skyhawk Therapeutics Collaborate on RNA Targeting Research
Aim to discover and develop small molecules for the treatment of rare neurological diseases.04.22.24
-
Breaking News | Drug Development | Promotions & Moves
SystImmune Names New CEO
Taps former Bristol Myers Squibb exec with 20 years’ experience in the biopharmaceutical industry.04.22.24
-
Breaking News | Drug Development | Trials & Filings
Genentech's Alecensa Approved in Early-Stage NSCLC
Phase III ALINA study demonstrates Alecensa reduced the risk of disease recurrence or death by 76%.04.19.24
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Development | Industry News
ExoXpert, Neucore Bio to Evaluate Advanced Exosome Loading
Aims to enable greater clarity on maximizing the therapeutic effect of Neucore’s FiXE platform as it advances clinical development.04.18.24
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Evotec and Variant Bio Partner to Discover & Develop Treatments for Fibrosis
The partnership leverages Variant Bio’s genomic discovery capabilities and VB-Inference platform as well as Evotec’s expertise in antifibrotic drug discovery.04.18.24
-
Breaking News | Drug Development | Industry News | Information Technology
Tris Pharma Launches Digital Health Business
Through licensing agreement with Braingaze aims to develop and commercialize digital products for ADHD.04.17.24
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Drug Development
CordenPharma, GENEPEP Celebrate R&D Alliance
Leverages peptide drug substance discovery and clinical development expertise.04.17.24
-
Breaking News | Collaborations & Alliances | Drug Development
CureVac, MD Anderson Enter Strategic Cancer Vax Pact
Aims to develop differentiated cancer vaccine candidates in selected hematological and solid tumor indications.04.16.24
-
Breaking News | Chemistry | Collaborations & Alliances | Drug Development | Formulation Development | Preclinical Outsourcing
Medincell, Abbvie Enter Development and Commercialization Pact
Medincell will provide formulation activities and preclinical studies, including supportive CMC work to advance candidates into trials.04.16.24
-
Breaking News | Drug Development
Viatris Welcomes Corinne Le Goff as Chief Commercial Officer
Le Goff is a biotechnology and pharmaceutical executive with more than 25 years of experience leading and building teams globally.04.15.24
-
Bio News | Breaking News | Drug Development
Applied Therapeutics Names New Chief Commercial Officer
Dale Hooks joins Applied with over 30 years of biopharmaceutical experience in rare disease marketing and sales.04.15.24
-
Drug Development | Trials & Filings
Genentech’s Columvi Meets Primary Endpoint in DLBCL
Phase III study demonstrated that people lived longer when treated with Columvi in combination with gemcitabine and oxaliplatin.04.15.24
